Millipore Sigma Vibrant Logo

MAB360 Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5

100 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
Request Pricing
Limited Availability
Limited Availability
Limited Quantities Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers


      Contact Customer Service


      Replacement Information

      Key Specifications Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      B, Ch, H, M, Po, R, RbICC, IHC, IH(P), WBMAscitesMonoclonal Antibody
      Catalogue NumberMAB360
      Replaces04-1031; 04-1062
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Glial Fibrillary Acidic Protein Antibody, clone GA5
      Alternate Names
      • GFAP
      Background InformationGlial fibrillary acidic protein is a class-III intermediate filament. GFAP is the main constituent of intermediate filaments in astrocytes and serves as a cell specific marker that distinguishes differentiated astrocytes from other glial cells during the development of the central nervous system.
      Product Information
      • Positive Control: Cultured astrocytes, brain tissue (white matter), spinal chord, retina
      PresentationUnpurified mouse monoclonal IgG1 liquid in ascites fluid. Contains no preservative.
      Quality LevelMQ100
      ApplicationAnti-Glial Fibrillary Acidic Protein Antibody, clone GA5 detects level of Glial Fibrillary Acidic Protein & has been published & validated for use in IC, IH, IH(P) & WB with more than 65 product citations.
      Key Applications
      • Immunocytochemistry
      • Immunohistochemistry
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesImmunocytochemistry:
      A previous lot was used on cultured mammalian cells.

      1:400-1:800 dilution from a previous lot was used on alcohol-fixed paraffin embedded sections of rat brain (cerebrum or cerebellum) and human brain.

      Immunoblotting: A 1:1000 dilution of a previous lot was used.

      Optimal working dilutions must be determined by the end user
      Biological Information
      ImmunogenPurified GFAP from porcine spinal cord.
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      SpecificityGlial fibrillar acidic protein. On western blots of extracts from a human glioma cell line (U33CG/343MG), MAB360 recognizes a band at approximately 51 kDa corresponding to GFAP (Debus, 1983). By immunohistochemistry it recognizes astrocytes and Bergmann glia cells, glioma and glial cell derived tumors. Shows no cross-reactivity with vimentin.
      Species Reactivity
      • Bovine
      • Chicken
      • Human
      • Mouse
      • Pig
      • Rat
      • Rabbit
      Species Reactivity NoteReacts with Bovine, Chicken, Human, Mouse, Porcine (Pig), Rabbit and Rat. Reactivity with other species has not been determined.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. An additional transcript variant has been described, but its full length sequence has not been determined.
      Gene Symbol
      • GFAP
      • FLJ45472
      Purification MethodUnpurified
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P14136 # GFAP, a class-III intermediate filament, is a cell- specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
      SIZE: 432 amino acids; 49880 Da
      SUBUNIT: Isoform 3 interacts with N-terminus of PSEN1.
      SUBCELLULAR LOCATION: Cytoplasm. Note=Associated with intermediate filaments.
      DISEASE: SwissProt: P14136 # Defects in GFAP are a cause of Alexander disease [MIM:203450]. Alexander disease is a rare disorder of the central nervous system. It is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of Rosenthal fibers which are cytoplasmic inclusions in astrocytes. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death usually within the first decade. Infants with Alexander disease develop a leukoencephalopathy with macrocephaly, seizures, and psychomotor retardation. Patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course.
      SIMILARITY: SwissProt: P14136 ## Belongs to the intermediate filament family.
      Molecular Weight~ 51 kDa
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceRoutinely evaluated by Western Blot on Mouse brain lysates.

      Western Blot Analysis:
      1:1000 dilution of this lot detected GFAP on 10 μg of Mouse brain lysates.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20ºC from date of receipt.
      Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information


      Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5 SDS


      Safety Data Sheet (SDS) 

      Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5 Certificates of Analysis

      TitleLot Number
      Anti-Glial Fibrillary Acidic Protein, -2549361 2549361
      Anti-Glial Fibrillary Acidic Protein, -2798578 2798578
      Anti-Glial Fibrillary Acidic Protein, clone GA5 3074992
      Anti-Glial Fibrillary Acidic Protein, clone GA5 (mouse monoclonal) Monoclonal Antibody Q2909944
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 2328018 2328018
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 2390523 2390523
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 2446769 2446769
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 1940527 1940527
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 1987050 1987050
      Anti-Glial Fibrillary Acidic Protein, clone GA5 - 2041104 2041104


      Reference overviewApplicationSpeciesPub Med ID
      Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior.
      Baek, JH; Schmidt, E; Viceconte, N; Strandgren, C; Pernold, K; Richard, TJ; Van Leeuwen, FW; Dantuma, NP; Damberg, P; Hultenby, K; Ulfhake, B; Mugnaini, E; Rozell, B; Eriksson, M
      Human molecular genetics  24  1305-21  2015

      Show Abstract
      25343989 25343989
      Dysregulation of astrocyte extracellular signaling in Costello syndrome.
      Krencik, R; Hokanson, KC; Narayan, AR; Dvornik, J; Rooney, GE; Rauen, KA; Weiss, LA; Rowitch, DH; Ullian, EM
      Science translational medicine  7  286ra66  2015

      Show Abstract
      Western Blotting25947161 25947161
      Characterization of glioma stem-like cells from human glioblastomas.
      Yamamuro, S; Okamoto, Y; Sano, E; Ochiai, Y; Ogino, A; Ohta, T; Hara, H; Ueda, T; Nakayama, T; Yoshino, A; Katayama, Y
      International journal of oncology  47  91-6  2015

      Show Abstract
      25955568 25955568
      Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
      Praet, J; Orije, J; Kara, F; Guglielmetti, C; Santermans, E; Daans, J; Hens, N; Verhoye, M; Berneman, Z; Ponsaerts, P; Van der Linden, A
      NMR in biomedicine  28  505-13  2015

      Show Abstract
      25802215 25802215
      The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene
      Marta Luna-Sánchez 1 , Elena Díaz-Casado 1 , Emanuele Barca 2 , Miguel Ángel Tejada 3 , Ángeles Montilla-García 3 , Enrique Javier Cobos 3 , Germaine Escames 1 , Dario Acuña-Castroviejo 1 , Catarina M Quinzii 2 , Luis Carlos López
      EMBO Mol Med  7(5)  670-87  2015

      Show Abstract
      25802402 25802402
      Identification of Spinal Cord MicroRNA and Gene Signatures in a Model of Chronic Stress-Induced Visceral Hyperalgesia in Rat.
      Bradesi, S; Karagiannides, I; Bakirtzi, K; Joshi, SM; Koukos, G; Iliopoulos, D; Pothoulakis, C; Mayer, EA
      PloS one  10  e0130938  2015

      Show Abstract
      26222740 26222740
      Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline.
      Cho, KO; Lybrand, ZR; Ito, N; Brulet, R; Tafacory, F; Zhang, L; Good, L; Ure, K; Kernie, SG; Birnbaum, SG; Scharfman, HE; Eisch, AJ; Hsieh, J
      Nature communications  6  6606  2015

      Show Abstract
      25808087 25808087
      miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement.
      Gu, QH; Yu, D; Hu, Z; Liu, X; Yang, Y; Luo, Y; Zhu, J; Li, Z
      Nature communications  6  6789  2015

      Show Abstract
      25858512 25858512
      Protein carbonylation after traumatic brain injury: cell specificity, regional susceptibility, and gender differences.
      Lazarus, RC; Buonora, JE; Jacobowitz, DM; Mueller, GP
      Free radical biology & medicine  78  89-100  2015

      Show Abstract
      25462645 25462645
      Spinal autophagy is differently modulated in distinct mouse models of neuropathic pain.
      Berliocchi, L; Maiarù, M; Varano, GP; Russo, R; Corasaniti, MT; Bagetta, G; Tassorelli, C
      Molecular pain  11  3  2015

      Show Abstract
      25645145 25645145

      Related Products & Applications

      Related Products

      Catalog Number Description  
      AB5541 Anti-Glial Fibrillary Acidic Protein Antibody Show Pricing & Availability
      AB9598 Anti-Glial fibrillary acidic protein δ Antibody Show Pricing & Availability
      FCMAB257P Milli-Mark™Anti-Glial Fibrillary Acidic Protein-PE Antibody, clone GA5 Show Pricing & Availability
      MAB3402 Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5 Show Pricing & Availability
      MAB3402B Anti-GFAP Antibody, Biotin Conjugate | MAB3402B Show Pricing & Availability
      MAB3402C3 Anti-GFAP Antibody, Cy3 Conjugate Show Pricing & Availability
      MAB3402X Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5, Alexa Fluor® 488 Show Pricing & Availability
      MAB5628 Anti-Glial Fibrillary Acidic Protein Antibody Show Pricing & Availability

      Product Families


      Life Science Research > Antibodies and Assays > Primary Antibodies